Professional Documents
Culture Documents
Student’s Name
Course
Tutor’s Name
Date
2
studies to assess the severity of the condition. The NOS is now being evaluated, which is
currently underway. Affirmation has been provided for its content validity and inter-rater
reliability. A study is now being conducted to determine its criterion validity in contrast to more
extensive but time-consuming scales, as well as its intra-rater reliability. An evaluation strategy
for assessing the construct validity of the NOS is being developed, taking into account the
theoretical link of the NOS to external criteria as well as the internal structure of the NOS
It was decided to apply the Randomized Controlled Trial (RCT) Methodology Checklist
developed by the Agency for Healthcare Research and Quality (AHRQ), which contains 11
research, the Methodological Index for Non-Randomized Studies (MINORS) is an effective tool,
while the Agency for Healthcare Research and Quality (ARHQ) methodological checklist is
appropriate for cross-sectional studies. Prevalence studies are appraised, and primary prevalence
studies are conducted. We may also give a current version of or assistance in developing tools to
analyze prevalence studies, if needed. This paper presents a comprehensive set of items
classified by domains that can be used to guide the appraisal of prevalence studies, the conduct
of primary prevalence studies, and the updating or development of tools to evaluate the results of
prevalence studies. The items are organized into four categories. It may be necessary to
reevaluate iron supplementation parameters in order to achieve optimal iron sufficiency status. It
is possible that this trend reflects discrepancies in iron supplementation between our institution
3
and other newborn units (German et al. 2019). These findings demonstrate that high-dose enteral
iron supplementation has a positive effect on the iron status of preterm newborns.
4
References
German, K., Vu, P. T., Irvine, J. D., & Juul, S. E. (2019). Trends in reticulocyte hemoglobin
Perinatology, 39(9), 1268-1274.
Löfving, A., Domellöf, M., Hellström-Westas, L., & Andersson, O. (2018). Reference intervals
661.